The Association of the British Pharmaceutical Industry
Medicines are transforming our lives like never before.
We want the UK to be the best place in the world to research, develop and use the medicines and vaccines of the future.
Latest news and blogs
News |
Scotland's life sciences strategy is a welcome vision that must be matched with delivery, says ABPI
News |
ABPI calls for Budget action to revive UK life sciences investment
Blog |
International comparisons in medicines spending and the link to competitiveness
Blog |
ABPI Regulatory Science symposium 2025
Best practice guidance: Supporting patient organisations to report industry funding
Transparency is essential when pharmaceutical companies work with patient organisations. This updated guidance is aimed at supporting that transparency.
Guidance for conferences and events in the UK: ABPI Code of Practice requirements
This clarifies the ABPI Code requirements for conferences and events, helps all relevant stakeholders operate in a Code-compliant, professional and ethical manner.
2024 ABPI Code of Practice – new resources
The PMCPA has published new webinars and e-learning to aid understanding of the 2024 ABPI Code of Practice.
Lives Lived Well
From patients and their loved ones to those working within the pharmaceutical industry in the UK, we share a common goal: Lives Lived Well.
Events
Online Workshop on SMC: How to prepare and submit to SMC | 08 - 09 December 2025
Making high quality, evidence-based submissions to SMC can mean the difference between successful or very limited access to NHS Scotland for medicines.
ABPI Annual Conference 2026
ABPI’s flagship annual conference will be taking place in Central London on 23 April 2026.
Scotland's life sciences strategy is a welcome vision that must be matched with delivery, says ABPI
The Strategy aims to create the most effective environment for developing, testing, manufacturing and commercialising life sciences innovation.
Companies granted third extension to VPAG 2026 decision deadline – now set for 16 December
The ABPI and the government have agreed to a further extension to the deadline by which companies must give notice if they intend to leave the 2024 voluntary scheme for branded medicines pricing, access and growth (VPAG). The revised deadline for submitting notice to leave the VPAG scheme is now 16 December 2025.
Key facts and figures for the pharmaceutical industry in the UK
£46.7bn
Turnover [6]
£9bn
investment in UK R&D (more than UKRI’s entire annual budget) [3]
£17.6bn
direct Gross Value Added (GVA) [1]
Publications
- Attracting global talent: a pro-growth plan for UK life sciences
- Working together: Guidance to support transformative pharmaceutical industry partnerships with the NHS in Wales
- Reviewing implementation in practice of the NICE Health Technology Evaluation Manual - CONNIE October 2025